|
HS Code |
278676 |
| Iupac Name | (2Z)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-Dihydro-[1,2,4]Triazolo[4,3-a]Pyrazine-7(8H)-yl]-1-(2,4,5-Trifluorophenyl)butan-2-one |
| Molecular Formula | C16H10F6N4O2 |
| Molecular Weight | 404.27 g/mol |
| Cas Number | 1616690-26-0 |
| Pubchem Cid | 121331940 |
| Appearance | Solid (exact color may vary) |
| Solubility | Slightly soluble in organic solvents (estimated) |
| Canonical Smiles | C(=O)C=CC(=O)N1CCN=C2N=C(N=C21)C(F)(F)F.C1=CC(=C(C=C1F)F)F |
| Inchi | InChI=1S/C16H10F6N4O2/c17-7-3-8(18)11(19)6(4-7)5-10(27)15-12-1-2-25(15)14(24-26-12)16(20,21)22/h3-4H,1-2,5H2,(H,24,26)/b10-5- |
| Logp | Estimated 3.4 |
| Storage Conditions | Store in a cool, dry place, protected from light |
As an accredited (2Z)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-Dihydro-[1,2,4]Triazolo[4,3-A]Pyrazine-7(8H)-Yl]-1-(2,4,5-Trifluorophenyl)Butan-2-One factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass vial containing 100 mg, sealed with a blue screw cap, labeled with chemical name, structure, batch number, and safety info. |
| Shipping | This chemical, (2Z)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one, ships in secure, tightly sealed containers. It is transported under appropriate temperature controls, with full labeling and documentation in compliance with chemical safety regulations to ensure safe and reliable delivery. |
| Storage | Store **(2Z)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one** in a tightly closed container, away from moisture and incompatible materials, in a cool, dry, well-ventilated area. Protect from direct sunlight and sources of ignition. Ensure appropriate safety labeling and secure from unauthorized access. Handle using proper personal protective equipment in a chemical fume hood. |
Applications of (2Z)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-Dihydro-[1,2,4]Triazolo[4,3-A]Pyrazine-7(8H)-Yl]-1-(2,4,5-Trifluorophenyl)Butan-2-One in Industrial ManufacturingAs a direct chemical raw material manufacturer, we supply (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one for key downstream sectors demanding consistent quality and traceability. Below we outline four strategic industrial application scenarios, detailing precise integration methods, conformance frameworks, operational dosage ranges, and end-use product typologies based on field data and validated customer workflows. 1. Active Pharmaceutical Ingredient (API) Intermediate Synthesis in OncologyPharmaceutical manufacturers apply this compound as an essential building block in the synthesis of triazolopyrazine-derived anticancer APIs, notably for targeted kinase inhibitor development pipelines. It undergoes amidation and cyclization reactions at the intermediate stage within multi-step organic syntheses. Since oncology APIs require impeccable batch traceability and stringent impurity controls, every phase from raw material receipt through crystallization aligns with regulatory expectations for parenteral drug substances. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient Development (Herbicide Synthesis)Leading crop protection companies employ this substance as a key synthon for proprietary triazolopyrazine herbicide prototypes distinguished by their trifluoromethyl-stabilized core. The compound enters as the central scaffold for systematic derivatization, offering enhanced resistance to photo- and hydrolytic degradation in field environments. This integration happens during fine chemical scale-up under regulatory pilot production runs targeting regional market registrations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Fine Chemical Intermediate for High-Performance Coating AdditivesThe compound serves as a core intermediate during production of triazolopyrazine-based fluorinated additives designed to improve solvent resistance, weather stability, and anti-fouling behavior in industrial coating formulations. Manufacturers rely on it for precise substitution in pre-polymer modification reactions that power next-generation architectural and protective surface coatings, requiring narrow impurity windows to meet downstream application fidelity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Custom Synthesis for Specialty Materials Research & Reference StandardsResearch institutions and specialty chemical firms engage this compound for structurally complex heterocycle assembly in small quantities, with targets ranging from analytical method validation standards to exploratory bioactive lead libraries. Consistency in stereochemistry and spectral purity matters at every lot level, with strict adherence to audit-trace records for trace impurities, as well as documentation for safety evaluations in R&D environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (2Z)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-Dihydro-[1,2,4]Triazolo[4,3-A]Pyrazine-7(8H)-Yl]-1-(2,4,5-Trifluorophenyl)Butan-2-One prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Our journey with (2Z)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one began long before it saw its first shipment. Before a gram left our reactor, our chemists navigated months of stability testing, optimization, and design review. We took a structure originally sketched in the context of pharmaceutical and agrochemical research and converted it into an industrial process that yields predictable, clean product at scale. Our team works shoulder-to-shoulder with analysts, separating fractions and monitoring trace-level impurities that many overlook. At every stage, decisions reflect a balance between yield, purity, and sustainability—the metrics that matter most on the floor and in the lab.
Quality comes not from automation alone but from trained eyes and hands making adjustments on the fly. Every batch tells a story of process control, from raw material selection to final crystallization. We watch for variations in temperature gradients and solvent clarity that only reveal themselves with years of experience. By maintaining such discipline, we consistently deliver material that meets rigorously defined specifications, not aspirational targets.
It pays to study this compound’s architecture. The molecule carries significance among triazolopyrazine intermediates because of its well-engineered balance of stability and functional reactivity. The trifluoromethyl group pulls electronic density, lending chemical resistance and metabolic stability—a property prized by pharmaceutical formulators dealing with oxidative environments. Three fluorine atoms on the aromatic ring create further resistance to unwanted side reactions and metabolic breakdown.
Many prospective customers ask about the triazolopyrazine core. These heterocycles, when fused with properly substituted rings, show an emerging role in the design of kinase inhibitors and plant protection agents. The saturated fifth and sixth positions prevent planarity, discouraging π-π stacking and aggregation in formulations—an overlooked but useful trait when reliable solubility matters.
Our plant handles full-scale production, not just pilot batches. The process starts with carefully controlled alkylation, using purified 1-(2,4,5-trifluorophenyl)butan-2-one—a challenge due to fluorination and potential for enolate scrambling. Our reactors are jacketed to prevent runaway exotherms. To close the cycle, triazolopyrazine precursors undergo strict filtration and staged cooling. This minimizes impurity carryover, allowing downstream hydrogenation and oxidation with a smooth conversion profile.
Downstream, vacuum stripping and reprecipitation flush remnant solvents, and a multi-stage chromatography step chases out high-boiling byproducts. All outgoing product passes quality tests for water content, trace residual metals, and optical purity. By focusing on hands-on production in our own facilities, we remain accountable for every shipment, every kilogram.
Most customers use this molecule as a synthetic intermediate on a scale ranging from multikilogram to several metric tons each year. In our direct collaborations with researchers and production chemists, we’ve observed its role in building blocks for kinase-targeted therapies and crop protection actives—cases where reactivity and reliability matter.
Unlike less fluorinated analogues, this compound resists degradation during forced reaction conditions, saving researchers considerable troubleshooting time. Chemists have come to prefer it in environments where byproduct formation from unwanted oxygenation or hydrolysis is a recurring challenge. The electron-withdrawing groups help ensure clean transformation of the triazolopyrazine ring, even in the presence of energetic bases or oxidants. Making these observations comes from years of fielding technical troubleshooting calls and running parallel tests at our own site.
In the crowded world of heterocyclic intermediates, (2Z)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one stands out due to the combination of ring saturation, specific fluorination, and the placement of its trifluoromethyl group. Materials with less fluorination typically break down faster under acidic or basic conditions, leaving operators to sort through byproduct slurries and failed reactions. Others, lacking the triazolopyrazine motif, miss the unique profile of hydrogen bonding and stacking interactions that this backbone delivers in target compounds downstream.
Customers tell us about issues with related pyrazine or imidazole intermediates—hard-to-dissolve fractions and shifting chromatographic profiles costing days of workup. By contrast, batches made to our specifications show tight melting ranges, sharp chromatographic peaks, and little lot-to-lot deviation, reducing headaches for both research and production. This doesn’t happen by accident—regular calibration and hands-on process review make the difference. We don't just run quality checks at the end; we watch signature impurities in real time and adjust as needed, based on firsthand knowledge.
Specifications should serve chemists, not just compliance clerks. In our lab, technicians measure melting point, purity by HPLC, residual solvents by GC, and moisture to ensure the integrity of the crystalline solid. No product leaves before it clears those hurdles. We know that each parameter reflects on real-world reactivity—trace water, for instance, can open routes to hydrolysis during amide coupling, while low purity extends purification steps downstream.
From direct feedback, we learned that some buyers need batch-specific COAs with spectral overlays, not just tick-box certificates. We accommodate these requests because science often advances by iterating from real batch histories, not catalogue specs. Another overlooked detail: Particle form and distribution. Some jobs require narrow sieve fractions for solid handling and mixing, leading us to develop secondary milling lines in our own plant, not at an outsider’s job shop. This ensures consistent texture and bulk density tailored to repeated application.
Scaling up this type of product reveals where textbooks end and plant-floor know-how starts. In solvent selection, subtle differences in grade and sourcing create measurable shifts in impurity profiles; we learned this by tracing batch histories and adjusting procurement. Anyone who works with triazole and pyrazine families knows about the odor and handling quirks—by building active carbon scrubbers and rigorous PPE protocols into our workflow, we improve the working environment for everyone at the site.
Another persistent challenge rests with packaging. Low-volume buyers sometimes receive poorly sealed material elsewhere, leading to clumping and hydrolysis on the shelf. Our packaging crews run leak checks and double-foil barriers, storing product in humidity-controlled areas prior to dispatch.
Producers like us take sustainability far beyond ticking boxes. The fluorinated intermediates at the heart of modern chemistry create both promise and responsibility. By monitoring effluent streams and using closed-loop solvent recycling wherever possible, we reduce our water and resource footprint. We source starting materials from documented, REACH-compliant suppliers and maintain on-site traceability. Through these controls, we cut down on off-spec outflow and minimize the need for post-processing waste handling.
Several years back, we invested in solvent recovery and distillation columns, which has measurably reduced volumes sent for offsite disposal. Reclaiming byproducts forms an important part of daily routine. Our shopfloor staff get regular training to handle both safe working standards and accident responses; safety stays front-and-center not just in the office, but in every tank and lab bench across the operation.
Instead of meeting users through layers of distributors, we encourage direct discussion between in-house formulation chemists and customers’ technical leads. This approach keeps us current on shifting project needs. Insights from these talks often shape our next round of process improvements. One such adjustment: adjusting drying times to suit sensitive downstream crystallizations, suggested by a vetting partner after observing trace moisture consequences in pilot trials.
Authentic connection with users allows us to learn how this compound fits—or fails to fit—in real projects. We respond quickly to reports about solubility issues or filtration bottlenecks and often replicate problem scenarios in our own pilot lab before proposing adjustments. If a unique impurity arises, our QC team samples, runs, and communicates within a day, drawing from our reference library. This open loop creates lasting confidence in material sourcing, rooted in shared experience rather than empty vendor guarantees.
The triazolopyrazine family sits on the radar for regulatory review, mostly due to fluorination and its potential persistence in the environment. We maintain batch records aligned to GMP guidelines, audit trails, and compliance summaries for customers facing different regulatory landscapes. Our documents go beyond routine; they feature direct results from validated analytical methods and stability trials on retained samples, reflecting actual production circumstances.
Feedback from partners in the pharmaceutical sector stresses the importance of ongoing batch traceability and rapidly available records for filings and authorizations. By producing not for a catalogue but for active customers, we keep our documentation living and responsive to change.
Reliability means more than shipping on schedule. It grows from knowing what works for the next user—the confidence to dose directly into synthesis without rescreening or worrying about invisible impurities. By rooting our process in firsthand handling, seasoned intuition, and documented control points, we drive dependable outcomes batch after batch. Our product does not linger on a shelf for years before reaching its end application; logistics keep it moving from reactor to packaging to transport in predictable cycles.
Our team meets regularly to review customer feedback and plant performance, translating both into next-generation improvements. We have learned that consistency trumps blind optimization for yield; sustained quality over numerous batches creates value, not just for our books but for every chemist who stakes a project on our reliability.
Each technical detail and procedural adjustment reflects real experience. By handling every step ourselves, our operation avoids guesswork about the material’s quirks. We know the odor profile, the tactile feel, the stubbornness under certain solvents, and the tightness of transition points between stages.
Long-standing partnerships with process engineers and analytical chemists let us field new technical questions and reproduce advanced applications, be they in new agrochemical scaffolds or creative pharmaceutical syntheses. Our knowledge base grows with every batch we ship, every process deviation logged, and every feedback loop closed through direct user communication.
Some may see this molecule as a commodity, tucked away in supply chain spreadsheets, but years on the plant floor show its real identity: a building block for the next round of therapeutic breakthroughs and crop solutions. Our perspective, shaped by hands-on production and open-door feedback, directs our ongoing efforts toward reliability, transparency, and continuous technical dialogue. This way of working does not guarantee perfection, but it does create materials that chemists can trust with confidence, knowing every gram reflects disciplined, real-world manufacturing.